𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Novel mutations in EPM2A and NHLRC1 widen the spectrum of Lafora disease

✍ Scribed by Gaetan Lesca; Nadia Boutry-Kryza; Bertrand De Toffol; Mathieu Milh; Dominique Steschenko; Martine Lemesle-Martin; Louis Maillard; Giovanni Foletti; Gabrielle Rudolf; Jørgen Erik Nielsen; Bjarke á Rogvi-Hansen; Jesper Erdal; Josette Mancini; Christel Thauvin-Robinet; Amel M’Rrabet; Dorothée Ville; Pierre Szepetowski; Emmanuel Raffo; Edouard Hirsch; Philippe Ryvlin; Alain Calender; Pierre Genton


Book ID
109112816
Publisher
Wiley (Blackwell Publishing)
Year
2010
Tongue
English
Weight
508 KB
Volume
51
Category
Article
ISSN
0013-9580

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Lafora disease in the Indian population:
✍ Shweta Singh; Parthasarathy Satishchandra; Susarla Krishna Shankar; Subramaniam 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 344 KB

## Communicated by Claude Feréc Lafora disease (LD) is a fatal form of teenage-onset autosomal recessive progressive myoclonus epilepsy. LD is more common among geographic isolates and in populations with a higher rate of consanguinity. Mutations in two genes, EPM2A encoding laforin phosphatase, a

Mutational spectrum of the succinate sem
✍ Shinjiro Akaboshi; Boris M. Hogema; Andrea Novelletto; Patrizia Malaspina; Gajja 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 218 KB

Succinate semialdehyde dehydrogenase (SSADH; ALDH5A1) deficiency, a rare metabolic disorder that disrupts the normal degradation of GABA, gives rise to a highly heterogeneous neurological phenotype ranging from mild to very severe. The nature of the mutation has so far been reported in patients from